You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 301 No. 6, February 11, 2009 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (6)
 •Contact me when this article is cited
 Related Content
 •Related letters
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Patient-Physician Relationship/ Care
 •Patient Education/ Health Literacy
 •Renal Diseases
 •Renal Diseases, Other
 •Randomized Controlled Trial
 •Diet
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Effect of Food Additives on Hyperphosphatemia Among Patients With End-stage Renal Disease

A Randomized Controlled Trial

Catherine Sullivan, MS, RD, LD; Srilekha S. Sayre, MS, RD, LD; Janeen B. Leon, MS, RD, LD; Rhoderick Machekano, MPH, PhD; Thomas E. Love, PhD; David Porter, BA; Marquisha Marbury, AAS; Ashwini R. Sehgal, MD

JAMA. 2009;301(6):629-635.

Context  High dietary phosphorus intake has deleterious consequences for renal patients and is possibly harmful for the general public as well. To prevent hyperphosphatemia, patients with end-stage renal disease limit their intake of foods that are naturally high in phosphorus. However, phosphorus-containing additives are increasingly being added to processed and fast foods. The effect of such additives on serum phosphorus levels is unclear.

Objective  To determine the effect of limiting the intake of phosphorus-containing food additives on serum phosphorus levels among patients with end-stage renal disease.

Design, Setting, and Participants  Cluster randomized controlled trial at 14 long-term hemodialysis facilities in northeast Ohio. Two hundred seventy-nine patients with elevated baseline serum phosphorus levels (>5.5 mg/dL) were recruited between May and October 2007. Two shifts at each of 12 large facilities and 1 shift at each of 2 small facilities were randomly assigned to an intervention or control group.

Intervention  Intervention participants (n=145) received education on avoiding foods with phosphorus additives when purchasing groceries or visiting fast food restaurants. Control participants (n=134) continued to receive usual care.

Main Outcome Measure  Change in serum phosphorus level after 3 months.

Results  At baseline, there was no significant difference in serum phosphorus levels between the 2 groups. After 3 months, the decline in serum phosphorus levels was 0.6 mg/dL larger among intervention vs control participants (95% confidence interval, –1.0 to –0.1 mg/dL). Intervention participants also had statistically significant increases in reading ingredient lists (P<.001) and nutrition facts labels (P = .04) but no significant increase in food knowledge scores (P = .13).

Conclusion  Educating end-stage renal disease patients to avoid phosphorus-containing food additives resulted in modest improvements in hyperphosphatemia.

Trial Registration  clinicaltrials.gov Identifier: NCT00583570


Author Affiliations: Division of Nephrology (Mss Sullivan, Sayre, Leon, and Marbury, Mr Porter, and Dr Sehgal) and Center for Health Care Research and Policy (Drs Machekano, Love, and Sehgal), MetroHealth Medical Center, and Center for Reducing Health Disparities (Mss Sullivan, Sayre, Leon, and Marbury, Mr Porter, and Dr Sehgal), and Departments of Medicine (Mss Sullivan, Sayre, Leon, and Marbury, Mr Porter, and Drs Machekano, Love, and Sehgal), Epidemiology and Biostatistics (Dr Sehgal), and Bioethics (Dr Sehgal), Case Western Reserve University, Cleveland, Ohio.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED LETTERS

Reducing Serum Phosphorus Concentration in Patients With End-Stage Renal Disease
Antonio Alberto Lopes and Gildete Barreto Lopes
JAMA. 2009;301(23):2443-2444.
EXTRACT | FULL TEXT  

Reducing Serum Phosphorus Concentration in Patients With End-Stage Renal Disease—Reply
Ashwini R. Sehgal, Catherine Sullivan, and Srilekha S. Sayre
JAMA. 2009;301(23):2444.
EXTRACT | FULL TEXT  

RELATED ARTICLE

Kidney Failure
Lise M. Stevens, Cassio Lynm, and Richard M. Glass
JAMA. 2009;301(6):686.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Phosphorus Additives in Food and their Effect in Dialysis Patients
Uribarri
CJASN 2009;4:1290-1292.
FULL TEXT  

Phosphorus and Potassium Content of Enhanced Meat and Poultry Products: Implications for Patients Who Receive Dialysis
Sherman and Mehta
CJASN 2009;4:1370-1373.
ABSTRACT | FULL TEXT  

Why Is the Mortality of Dialysis Patients in the United States Much Higher than the Rest of the World?
Foley and Hakim
J. Am. Soc. Nephrol. 2009;20:1432-1435.
FULL TEXT  

Reducing Serum Phosphorus Concentration in Patients With End-Stage Renal Disease
Lopes and Lopes
JAMA 2009;301:2443-2444.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.